OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Takeda Pharmaceutical Co Ltd/  US8740602052  /

IEX
11/15/2024  9:59:56 PM Chg. +0.05 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
13.63USD +0.37% 166,236
Turnover: 2.26 mill.		 -Bid Size: - -Ask Size: - 42.54 bill.USD - -

Assets

 2018
-
in mill. JPY		 2019
-
in mill. JPY		 2020
IFRS
in mill. JPY		 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Property and Equipment
  536,801   1.32 mill.   1.39 mill.   1.45 mill.   1.58 mill.
Intangible Assets
  1.01 mill.   4.86 mill.   4.17 mill.   3.91 mill.   3.82 mill.
Long-Term Investments
  107,949   114,658   262,121   235,882   96,579
Fixed Assets
  -   -   -   -   10.58 mill.
Inventories
  212,944   986,744   759,599   753,881   853,167
Accounts Receivable
  420,247   741,907   757,005   783,091   696,644
Cash and Cash Equivalents
  294,522   702,093   637,614   966,222   849,695
Current Assets
  1.08 mill.   3.05 mill.   2.47 mill.   2.71 mill.   2.59 mill.
Total Assets
  4.11 mill.   13.87 mill.   12.82 mill.   12.91 mill.   13.18 mill.

 

Liabilities

 2018
-
in mill. JPY		 2019
-
in mill. JPY		 2020
IFRS
in mill. JPY		 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Accounts Payable
  240,259   327,394   318,816   343,838   516,297
Long-term debt
  -   -   -   -   4.14 mill.
Liabilities to Banks
  18   984,946   586,817   22,153   -
Provisions
  186,461   1.02 mill.   930,490   726,803   947,212
Liabilities
  2.09 mill.   8.71 mill.   8.09 mill.   7.74 mill.   7.49 mill.
Share Capital
  77,914   1.64 mill.   1.67 mill.   1.67 mill.   -
Total Equity
  2.02 mill.   5.16 mill.   4.73 mill.   5.18 mill.   5.68 mill.
Minority Interests
  19,985   4,006   4,003   4,140   504
Total liabilities equity
  4.11 mill.   13.87 mill.   12.82 mill.   12.91 mill.   13.18 mill.

 

Income Statement

 2018
-
in mill. JPY		 2019
-
in mill. JPY		 2020
IFRS
in mill. JPY		 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Revenues
  1.77 mill.   2.1 mill.   3.29 mill.   3.2 mill.   3.57 mill.
Depreciation (total)
  122,131   203,372   455,420   421,864   472,915
Operating Result
  241,789   204,969   100,408   509,269   460,844
Interest Income
  7,615   -66,446   -137,175   -143,110   -142,907
Income Before Taxes
  217,205   94,896   -60,754   366,235   -
Income Taxes
  30,497   -14,118   -105,044   -9,936   72,405
Minority Interests Profit
  178   112   -49   -166   -107
Net Income
  186,886   109,126   44,241   376,005   230,059

 

Per Share

 2018
-
in JPY		 2019
-
in JPY		 2020
IFRS
in JPY		 2021
IFRS
in JPY		 2022
IFRS
in JPY
Earnings per Share
  239.3500   140.6100   28.4100   240.7200   147.1400
Dividend per Share
  -   -   -   -   -

 

Cash Flow

 2018
-
in mill. JPY		 2019
-
in mill. JPY		 2020
IFRS
in mill. JPY		 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Cash Flow from Operating Activities
  377,854   328,479   669,752   1.01 mill.   1.12 mill.
Cash Flow from Investing Activities
  -93,342   -2.84 mill.   292,119   393,530   -198,125
Cash Flow from Financing
  -326,226   2.95 mill.   -1.01 mill.   -1.09 mill.   -1.07 mill.
Decrease / Increase in Cash
  -41,714   439,018   -43,342   316,107   -
Employees
  27,230   49,578   47,495   47,099   47,000